Men pick robotic surgery for prostate cancer despite risks
Pretty much every medical organization has told men to back off on screening for prostate cancer, because it can lead to unneeded treatment, including surgery that can leave a man incontinent and impotent. But it's hard to resist a robot. Men who have been diagnosed with low-grade prostate cancer increasingly choose expensive newer treatments including robotic surgery and a radiation treatment called intensity-modulated radiotherapy, or IMRT, even though they are not likely to benefit from those treatments, according to a in JAMA, the journal of the American Medical Association.
- How Top-Ranked MA Plans Earn Their Stars
- WellPoint Dominates Nearly Half of Markets, AMA Says
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- How Hospitals Can Become 'Upstreamists'
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- Providers Ask HHS to Address EHR Interoperability Barriers
- 5 Digital Marketing Efforts Every Hospital Should Try
- 16 Medicare Advantage Plans Earn 5-Star Ratings
- Ebola: A Call for Designated Hospitals
- The Drug Price Reform Debate